Mo
Momenta (J&J)
Cambridge MAFounded 2001200 employees
Private CapbiotechAcquiredImmunology
Platform: Biosimilar
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MOM-980 | MOM-980 | Preclinical | 1 | TYK2 | TTR AmyloidosisDMD | ||
| MOM-9396 | MOM-9396 | Phase 1 | 2 | RET | Huntington's | ||
| MOM-2836 | MOM-2836 | Phase 1/2 | 1 | APOC3 | RB |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)